Back to top
more

GoHealth (GOCO)

(Real Time Quote from BATS)

$5.68 USD

5.68
8,893

+0.12 (2.16%)

Updated Aug 4, 2025 11:38 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth C Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 18% (44 out of 246)

Industry: Insurance - Life Insurance

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Reinsurance Group (RGA) Q2 Earnings and Revenues Lag Estimates

by Zacks Equity Research

Reinsurance Group (RGA) delivered earnings and revenue surprises of -15.41% and -1.09%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

GoHealth (GOCO) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

GoHealth (GOCO) delivered earnings and revenue surprises of -80.77% and 2.77%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Lincoln National (LNC) Q1 Earnings Top Estimates

by Zacks Equity Research

Lincoln National (LNC) delivered earnings and revenue surprises of 3.90% and 0.52%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Primerica (PRI) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Primerica (PRI) delivered earnings and revenue surprises of 5.24% and 2.06%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Brighthouse Financial (BHF) Moves 13.8% Higher: Will This Strength Last?

by Zacks Equity Research

Brighthouse Financial (BHF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Zacks Equity Research

Down -24.97% in 4 Weeks, Here's Why GoHealth (GOCO) Looks Ripe for a Turnaround

by Zacks Equity Research

GoHealth (GOCO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Zacks Equity Research

Citizens (CIA) Surges 9.0%: Is This an Indication of Further Gains?

by Zacks Equity Research

Citizens (CIA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

GoHealth (GOCO) Surpasses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

GoHealth (GOCO) delivered earnings and revenue surprises of 107.76% and 21.98%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

F&G Annuities & Life, Inc. (FG) Lags Q4 Earnings Estimates

by Zacks Equity Research

F&G Annuities & Life, Inc. (FG) delivered earnings and revenue surprises of -11.11% and 22.28%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Citizens (CIA) Moves 5.9% Higher: Will This Strength Last?

by Zacks Equity Research

Citizens (CIA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

GoHealth (GOCO) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

GoHealth (GOCO) delivered earnings and revenue surprises of -16.93% and 11.67%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

GoHealth (GOCO) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

GoHealth (GOCO) delivered earnings and revenue surprises of 69.64% and 23.83%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Primerica (PRI) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Primerica (PRI) delivered earnings and revenue surprises of 5.84% and 0.78%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

F&G Annuities & Life, Inc. (FG) Q2 Earnings Top Estimates

by Zacks Equity Research

F&G Annuities & Life, Inc. (FG) delivered earnings and revenue surprises of 12.24% and 13.57%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

GoHealth (GOCO) Moves 9.2% Higher: Will This Strength Last?

by Zacks Equity Research

GoHealth (GOCO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Equity Research

Voya Financial (VOYA) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Voya (VOYA) delivered earnings and revenue surprises of 18.99% and 3.12%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

GoHealth (GOCO) Is Attractively Priced Despite Fast-paced Momentum

by Zacks Equity Research

GoHealth (GOCO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Zacks Equity Research

Is GoHealth (GOCO) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Here's Why You Should Hold on to Brighthouse Financial (BHF) Stock

by Zacks Equity Research

Brighthouse Financial (BHF) is well-poised for improvement on the growing individual insurance market, increasing sales of life insurance products, and a well-diversified and high-quality portfolio.

Zacks Equity Research

Here's Why You Should Invest in Voya Financial (VOYA) Stock

by Zacks Equity Research

Voya Financial (VOYA) stands to gain from favorable retention, positive impacts of the Benefitfocus acquisition, improved investment income, stronger surplus income and sufficient liquidity.

Zacks Equity Research

Are Options Traders Betting on a Big Move in GoHealth (GOCO) Stock?

by Zacks Equity Research

Investors need to pay close attention to GoHealth (GOCO) stock based on the movements in the options market lately.

Zacks Equity Research

Should Value Investors Buy GoHealth (GOCO) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Brighthouse (BHF) Enhances Annuity Suite With New Launch

by Zacks Equity Research

Brighthouse (BHF) boosts its annuity product suite with the launch of Brighthouse SecureKey Fixed Indexed Annuities.

Zacks Equity Research

Brighthouse (BHF) Announces Buyback Authorization Worth $750M

by Zacks Equity Research

Brighthouse's (BHF) board of directors declares a new share buyback plan to repurchase shares worth $750 million.

Zacks Equity Research

Here's Why You Should Hold Brighthouse Financial (BHF) Now

by Zacks Equity Research

Brighthouse Financial (BHF) gains from the growing individual insurance market, the sales of life insurance products, a well-diversified and high-quality portfolio and prudent capital deployment.